INITIAL ASSESSMENT OF TUMOR-ASSOCIATED ANTIGEN-CA-125 IN PATIENTS WITH OVARIAN, CERVICAL, AND TESTICULAR-TUMORS

被引：0
|
作者：
BUAMAH, PK
CORNELL, C
SKILLEN, AW
CANTWELL, BMJ
HARRIS, AL
机构：
[1] FREEMAN HOSP,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE7 7DN,ENGLAND
[2] NEWCASTLE GEN HOSP,DEPT CLIN ONCOL,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND
[3] MED SCH,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE2 4HH,ENGLAND
来源：
CLINICAL CHEMISTRY | 1987年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1124 / 1125
页数：2
相关论文
共 50 条
  • [31] EXPRESSION OF THE TUMOR-ASSOCIATED ANTIGEN CA-242 IN TRANSITIONAL-CELL BLADDER-TUMORS - A COMPARISON WITH CA-50
    LIPPONEN, P
    ESKELINEN, M
    HEMMILA, I
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (14) : 1935 - 1940
  • [32] ENHANCEMENT OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 ANTIGEN EXPRESSION IN HORMONE-RELATED OVARIAN SEROUS BORDERLINE TUMORS
    CAJIGAS, HE
    FARIZA, E
    SCULLY, RE
    THOR, AD
    CANCER, 1991, 68 (02) : 348 - 354
  • [33] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN HUMAN OVARIAN-CYST FLUID - COMPARISON WITH CA-125 AND CEA
    HALILA, H
    HUHTALA, ML
    HAGLUND, C
    NORDLING, S
    STENMAN, UH
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 153 - 156
  • [34] EVALUATION OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 AND CA-125 SERUM MARKERS IN PATIENTS WITH GYNECOLOGIC DISEASES
    GUADAGNI, F
    MARTH, C
    ZEIMET, AG
    FERRONI, P
    SPILA, A
    ABBOLITO, R
    ROSELLI, M
    GREINER, JW
    SCHLOM, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (05) : 1183 - 1191
  • [35] CLINICAL-EVALUATION OF TUMOR-ASSOCIATED MUCIN-TYPE GLYCOPROTEIN CA-54/61 IN OVARIAN CANCERS - COMPARISON WITH CA-125
    SUZUKI, M
    SEKIGUCHI, I
    TAMADA, T
    OBSTETRICS AND GYNECOLOGY, 1990, 76 (03): : 422 - 427
  • [36] TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer
    Peters-Engl, C
    Buxbaum, P
    Ogris, E
    Sevelda, P
    Medl, M
    ANTICANCER RESEARCH, 1998, 18 (6B) : 4635 - 4639
  • [37] EVALUATION OF 2 NEW ASSAYS FOR TUMOR-ASSOCIATED ANTIGENS, CASA AND OSA, FOUND IN THE SERUM OF PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA - COMPARISON WITH CA125
    MCGUCKIN, MA
    LAYTON, GT
    BAILEY, MJ
    HURST, T
    KHOO, SK
    WARD, BG
    GYNECOLOGIC ONCOLOGY, 1990, 37 (02) : 165 - 171
  • [38] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) - COMPARISON WITH CA125 AS A PREOPERATIVE PROGNOSTIC INDICATOR IN ADVANCED OVARIAN-CANCER
    VENESMAA, P
    LEHTOVIRTA, P
    STENMAN, UH
    LEMINEN, A
    FORSS, M
    YLIKORKALA, O
    BRITISH JOURNAL OF CANCER, 1994, 70 (06) : 1188 - 1190
  • [39] A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer
    Phocas, I
    Sarandakou, A
    Sikiotis, K
    Rizos, D
    Kalambokis, D
    Zourlas, PA
    ANTICANCER RESEARCH, 1996, 16 (6B) : 3827 - 3831
  • [40] COMPARISON OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) WITH CA125 AS A MARKER FOR DIAGNOSIS AND MONITORING OF EPITHELIAL OVARIAN-CANCER
    GADDUCCI, A
    FERDEGHINI, M
    RISPOLI, G
    PRONTERA, C
    BIANCHI, R
    FIORETTI, P
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 19 - 24
12345